Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 2
Abstract
For the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) hasbeen considered as the standard of care treatment for chronic hepatitis C virus (HCV) infection. However, it has been associated with an increased incidence of many adverse cutaneous reactions and emergence of autoantibodies or even autoimmune diseases. We report a case of irreversible alopecia universalis (AU) with complete hair loss extended to the whole body, which started after discontinuation of Peg-IFN/RBV combination therapy for chronic HCV infection. In conclusion, this case represents an uncommon presentation of a common disease. Physicians must be aware of the potential adverse reactions of an antiviral therapy containing IFN, which might occur even after the discontinuation, and fully inform the patient at the beginning of his treatment course. We hope that interferon-free regimens will utterly supplant interferon-based therapy for most or all HCV patients avoiding the emergence of autoimmune manifestations.
Authors and Affiliations
Nesrine Gamal, Lucia Brodosi, Cosimo Misciali, Annalisa Patrizi, Gentiana Vukatana, Nazzarena Malavolta, Mauro Bernardi, Pietro Andreone
Keywords
Related Articles
- EP ID EP78387
- DOI -
- Views 99
- Downloads 0
Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees
-
Recurrent giant cell hepatitis in an 18 year old liver transplant patient
Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis
Acute-on-chronic liver failure (ACLF) is associated with increased short and long-term mortality. Animal models of liver failure have demonstrated that granulocyte-colony stimulating factor (G-CSF) accelerates the liver...
Annals Impact Factor 1.67. Welcome to the IF club: achievement and challeng
Focal nodular hyperplasia and hepatic regenerating nodules in pediatric oncology patients: how much invasive approach is necessary?
[b]Introduction[/b]. Hepatic regenerating nodules (HRN) and focal nodular hyperplasia (FNH) are benign regenerating lesions of the liver that rarely occur in children. An increased incidence of these lesions is reported...